Takuji Murata

1.9k total citations · 1 hit paper
41 papers, 1.3k citations indexed

About

Takuji Murata is a scholar working on Hematology, Speech and Hearing and Rheumatology. According to data from OpenAlex, Takuji Murata has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 13 papers in Speech and Hearing and 10 papers in Rheumatology. Recurrent topics in Takuji Murata's work include Autoimmune and Inflammatory Disorders Research (20 papers), Adolescent and Pediatric Healthcare (13 papers) and Antioxidant Activity and Oxidative Stress (10 papers). Takuji Murata is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (20 papers), Adolescent and Pediatric Healthcare (13 papers) and Antioxidant Activity and Oxidative Stress (10 papers). Takuji Murata collaborates with scholars based in Japan, Australia and United States. Takuji Murata's co-authors include Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori, Mari Miyoshi, Minako Tomiita, Naomi Iwata, Takako Miyamae, Tadamitsu Kishimoto, Norihiro Nishimoto and Hiroshi Tamai and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Annals of the New York Academy of Sciences.

In The Last Decade

Takuji Murata

38 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

2008 579 citations Shumpei Yokota, Tomoyuki Imagawa et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takuji Murata Japan	18	706	321	312	278	244	41	1.3k
H. Iven Germany	19	161 0.2×	193 0.6×	355 1.1×	119 0.4×	113 0.5×	58	1.8k
Kim Nguyen South Africa	20	186 0.3×	272 0.8×	128 0.4×	14 0.1×	62 0.3×	55	1.1k
Fumio Yanai Japan	16	184 0.3×	133 0.4×	71 0.2×	29 0.1×	31 0.1×	33	898
José A. Aznar Spain	26	1.4k 2.0×	63 0.2×	187 0.6×	21 0.1×	30 0.1×	100	1.9k
Türkiz Gursel Türkiye	17	558 0.8×	111 0.3×	108 0.3×	18 0.1×	57 0.2×	66	953
Roman Crazzolara Austria	17	217 0.3×	164 0.5×	385 1.2×	15 0.1×	36 0.1×	58	1.1k
D S Rampton United Kingdom	20	100 0.1×	201 0.6×	218 0.7×	20 0.1×	135 0.6×	49	1.7k
Surender Rajasekaran United States	18	161 0.2×	115 0.4×	281 0.9×	21 0.1×	10 0.0×	64	987
N Raknerud Norway	19	133 0.2×	112 0.3×	175 0.6×	8 0.0×	100 0.4×	43	1.6k
Arthur Sawitsky United States	23	260 0.4×	306 1.0×	278 0.9×	10 0.0×	75 0.3×	71	1.8k

Countries citing papers authored by Takuji Murata

Since Specialization

Citations

This map shows the geographic impact of Takuji Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuji Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuji Murata more than expected).

Fields of papers citing papers by Takuji Murata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuji Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuji Murata. The network helps show where Takuji Murata may publish in the future.

Co-authorship network of co-authors of Takuji Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Takuji Murata. A scholar is included among the top collaborators of Takuji Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuji Murata. Takuji Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakano, Naoko, Masaaki Mori, Hiroaki Umebayashi, et al.. (2017). Characteristics and outcome of intractable vasculitis syndrome in children: Nation-wide survey in Japan. Modern Rheumatology. 28(4). 697–702. 3 indexed citations

Imagawa, Tomoyuki, Syuji Takei, Hiroaki Umebayashi, et al.. (2012). Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan. Clinical Rheumatology. 31(12). 1713–1721. 58 indexed citations

Yokota, Shumpei, Tomoyuki Imagawa, Syuji Takei, et al.. (2011). Guidance on using tocilizumab for juvenile idiopathic arthritis. Modern Rheumatology. 21(6). 563–571. 11 indexed citations

Mori, Masaaki, Takuji Murata, Syuji Takei, Tomoyuki Imagawa, & Shumpei Yokota. (2011). Acquisition of expanded indications for intravenous cyclophosphamide in the management of childhood rheumatic disease in general. Modern Rheumatology. 21(5). 449–457.

Imagawa, Tomoyuki, Shumpei Yokota, Masaaki Mori, et al.. (2011). Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis. Modern Rheumatology. 22(1). 109–115. 59 indexed citations

Yokota, Shumpei, Tomoyuki Imagawa, Syuji Takei, et al.. (2011). Guidance on using tocilizumab for juvenile idiopathic arthritis. Modern Rheumatology. 21(6). 563–571. 6 indexed citations

Mori, Masaaki, Takuya Naruto, Tomoyuki Imagawa, et al.. (2009). Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan. Modern Rheumatology. 19(1). 1–11. 8 indexed citations

Ashida, Akira, Hideki Matsumura, Takuji Murata, et al.. (2009). A Case Report of Successful Treatment With Plasma Exchange for Hemophagocytic Syndrome Associated With Severe Systemic Juvenile Idiopathic Arthritis in an Infant Girl. Therapeutic Apheresis and Dialysis. 13(1). 71–76. 17 indexed citations

Mori, Masaaki, Takuya Naruto, Tomoyuki Imagawa, et al.. (2008). Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan. Modern Rheumatology. 19(1). 1–11. 19 indexed citations

10.

Yokota, Shumpei, Tomoyuki Imagawa, Masaaki Mori, et al.. (2008). Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. The Lancet. 371(9617). 998–1006. 579 indexed citations breakdown →

11.

Murata, Takuji, et al.. (2008). Four cases of arthritis associated with Mycoplasma pneumoniae infection. Pediatrics International. 50(4). 511–513. 23 indexed citations

12.

Imagawa, Tomoyuki, Masahiko Mori, Takako Miyamae, et al.. (2007). Efficacy and safety of tocilizumab in 48-week treatment in children with systemic juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 66. 110. 1 indexed citations

13.

Yokota, Shumpei, Masaaki Mori, Tomoyuki Imagawa, et al.. (2007). Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007). Modern Rheumatology. 17(5). 353–363. 17 indexed citations

14.

Okamoto, Nami, Takuji Murata, Hiroshi Tamai, Hiroyuki Tanaka, & Hiroichi Nagai. (2006). Effects of Alpha Tocopherol and Probucol Supplements on Allergen-Induced Airway Inflammation and Hyperresponsiveness in a Mouse Model of Allergic Asthma. International Archives of Allergy and Immunology. 141(2). 172–180. 40 indexed citations

15.

Miyamae, Takako, Masaaki Mori, Yasuji Inamo, et al.. (2003). [Multi-center analysis of calcinosis in children with juvenile dermatomyositis].. PubMed. 43(3). 538–43. 8 indexed citations

16.

Morinobu, Takao, Takuji Murata, Ryuzo Takaya, & Hiroshi Tamai. (2002). Nutritional Status of beta-Carotene, alpha-Tocopherol and Retinol in Obese Children. International Journal for Vitamin and Nutrition Research. 72(3). 119–123. 21 indexed citations

17.

Takitani, Kimitaka, Han‐Suk Kim, Takuji Murata, et al.. (2002). α-Tocopherol Transfer Protein Expression in Rat Liver Exposed to Hyperoxia. Free Radical Research. 36(9). 933–938. 24 indexed citations

18.

Morinobu, Takao, Hiroshi Tamai, Takuji Murata, et al.. (1994). Changes in .BETA.-Carotene Levels by Long-Term Administration of Natural .BETA.-Carotene Derived from Dunaliella bardawil in Humans.. Journal of Nutritional Science and Vitaminology. 40(5). 421–430. 7 indexed citations

19.

Tanabe, Takuya, Naohisa Kawamura, Takao Morinobu, et al.. (1994). Antioxidant enzymes and vitamins in Down's syndrome. Pathophysiology. 1(2). 93–97. 7 indexed citations

20.

Tamai, Hiroshi, Takuji Murata, Takao Morinobu, et al.. (1993). Bioavailability of β‐ Carotene in a Carotenoid Preparation Derived from Dunaliella bardawil in Human Male Adults. Annals of the New York Academy of Sciences. 691(1). 238–240. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact